Company Filing History:

12 out of 136

Zambon Group S.p.a.

Years Active: 1987-1998

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5807894 - Syrup containing N-acetyl-cysteine (1998-09-15),

2. 5693312 - Pharmaceutical composition having analgesic activity (1997-12-02),

3. 5645857 - Pharmaceutical composition having analgesic activity (1997-07-08),

4. 5519054 - Pharmaceutical compositions containing N-acetyl-cysteine derivatives (1996-05-21),

5. 5510385 - Pharmaceutical compositions containing the salts of (1996-04-23),

6. 5510101 - Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and (1996-04-23),

7. 5500226 - Pharmaceutical composition having analgesic activity (1996-03-19),

8. 5488069 - Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and (1996-01-30),

9. 5463117 - Process for the preparation of salts of 2-(4-isobutylphenyl)propionic (1995-10-31),

10. 5459157 - Pharmaceutical composition for ophthalmic use comprising a nonsteroidal (1995-10-17),

11. 5312627 - Transdermal therapeutic system for the administration of drugs having (1994-05-17),

12. 5227404 - Pharmaceutical composition for the treatment of glaucomatous optic (1993-07-13),

13. 4834966 - Pharmaceutical composition with analgesic activity (1989-05-30),

14. 4689218 - Effervescent composition with analgesic activity (1987-08-25),

Title: Inventor Spotlight: Annibale Gazzaniga

Introduction

Annibale Gazzaniga, a prominent inventor based in Rescaldina, Italy, has made significant contributions to the field of pharmaceuticals. With a robust portfolio of 14 patents, Gazzaniga's innovations reflect his commitment to enhancing health outcomes.

Latest Patents

Among his latest inventions are two noteworthy patents. The first is a syrup containing N-acetyl-cysteine, designed to be stable for at least two years. This syrup features a pleasant taste and smell and consists of an aqueous solution of NAC, a sweetening agent, and a thickening agent. Additionally, it may contain a flavoring agent and a preservative, with a pH level maintained between 5 and 8. The second patent involves a pharmaceutical composition that possesses analgesic activity. This composition incorporates (S)-2-(6-methoxy-2-naphthyl)-propionic acid as an active ingredient, combined with arginine, thus facilitating the development of effective oral pharmaceutical forms.

Career Highlights

Gazzaniga's career has been marked by his work with reputable companies. He has been associated with the Zambon Group S.p.A. and Zambon S.p.A., where he has played a pivotal role in advancing pharmaceutical innovations. His dedication and expertise have allowed him to navigate complex projects and enhance product offerings in the marketplace.

Collaborations

Throughout his career, Gazzaniga has collaborated with a team of talented professionals. Notable coworkers include Federico Stroppolo and Daniele Bonadeo, with whom he has shared insights and knowledge, contributing to fruitful innovations in the field.

Conclusion

Annibale Gazzaniga's contributions to the pharmaceutical industry through his inventive spirit and partnership with esteemed companies illustrate the value of innovation in improving health solutions. His latest patents are a testament to his expertise and commitment to advancing health-related products.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.